247 related articles for article (PubMed ID: 16918136)
1. Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers.
Noda H; Kato Y; Yoshikawa H; Arai M; Togashi K; Nagai H; Konishi F; Miki Y
J Exp Clin Cancer Res; 2006 Jun; 25(2):235-42. PubMed ID: 16918136
[TBL] [Abstract][Full Text] [Related]
2. Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors.
Sakamoto N; Terai T; Ajioka Y; Abe S; Kobayasi O; Hirai S; Hino O; Watanabe H; Sato N; Shimoda T; Fujii H
Oncogene; 2004 Nov; 23(55):8900-7. PubMed ID: 15480433
[TBL] [Abstract][Full Text] [Related]
3. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.
Kang S; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
Gynecol Oncol; 2007 Jun; 105(3):662-6. PubMed ID: 17360030
[TBL] [Abstract][Full Text] [Related]
4. K-ras mutations and RASSF1A promoter methylation in colorectal cancer.
van Engeland M; Roemen GM; Brink M; Pachen MM; Weijenberg MP; de Bruïne AP; Arends JW; van den Brandt PA; de Goeij AF; Herman JG
Oncogene; 2002 May; 21(23):3792-5. PubMed ID: 12032847
[TBL] [Abstract][Full Text] [Related]
5. Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.
Oliveira C; Velho S; Domingo E; Preto A; Hofstra RM; Hamelin R; Yamamoto H; Seruca R; Schwartz S
Oncogene; 2005 Nov; 24(51):7630-4. PubMed ID: 16007118
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D
J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation.
Nagasaka T; Sasamoto H; Notohara K; Cullings HM; Takeda M; Kimura K; Kambara T; MacPhee DG; Young J; Leggett BA; Jass JR; Tanaka N; Matsubara N
J Clin Oncol; 2004 Nov; 22(22):4584-94. PubMed ID: 15542810
[TBL] [Abstract][Full Text] [Related]
8. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY
Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234
[TBL] [Abstract][Full Text] [Related]
9. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
Park HW; Kang HC; Kim IJ; Jang SG; Kim K; Yoon HJ; Jeong SY; Park JG
Int J Cancer; 2007 Jan; 120(1):7-12. PubMed ID: 17013898
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.
Miranda E; Destro A; Malesci A; Balladore E; Bianchi P; Baryshnikova E; Franchi G; Morenghi E; Laghi L; Gennari L; Roncalli M
Br J Cancer; 2006 Oct; 95(8):1101-7. PubMed ID: 16969349
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma.
Tomizawa Y; Kohno T; Kondo H; Otsuka A; Nishioka M; Niki T; Yamada T; Maeshima A; Yoshimura K; Saito R; Minna JD; Yokota J
Clin Cancer Res; 2002 Jul; 8(7):2362-8. PubMed ID: 12114441
[TBL] [Abstract][Full Text] [Related]
12. RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma.
Kang S; Lee JM; Jeon ES; Lee S; Kim H; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
Int J Cancer; 2006 Sep; 119(6):1316-21. PubMed ID: 16619251
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic profiling in early colorectal tumors and prediction of invasive potential in pT1 (early invasive) colorectal cancers.
Nosho K; Yamamoto H; Takahashi T; Mikami M; Taniguchi H; Miyamoto N; Adachi Y; Arimura Y; Itoh F; Imai K; Shinomura Y
Carcinogenesis; 2007 Jun; 28(6):1364-70. PubMed ID: 17183069
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of beta-catenin and the RAS-RAF signalling pathway in early flat-type colorectal tumours.
Mikami M; Nosho K; Yamamoto H; Takahashi T; Maehata T; Taniguchi H; Adachi Y; Imamura A; Fujita M; Hosokawa M; Itoh F; Imai K; Shinomura Y
Eur J Cancer; 2006 Nov; 42(17):3065-72. PubMed ID: 17011185
[TBL] [Abstract][Full Text] [Related]
15. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
[TBL] [Abstract][Full Text] [Related]
16. Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations.
Kim IJ; Kang HC; Jang SG; Kim K; Ahn SA; Yoon HJ; Yoon SN; Park JG
Carcinogenesis; 2006 Mar; 27(3):392-404. PubMed ID: 16219636
[TBL] [Abstract][Full Text] [Related]
17. APC and p53 mutations in de novo colorectal adenocarcinomas.
Aoki T; Takeda S; Yanagisawa A; Kato Y; Ajioka Y; Watanabe H; Kudo S; Nakamura Y
Hum Mutat; 1994; 3(4):342-6. PubMed ID: 8081386
[TBL] [Abstract][Full Text] [Related]
18. Oncosuppressor methylation: a possible key role in colon metastatic progression.
Tommasi S; Pinto R; Petriella D; Pilato B; Lacalamita R; Santini D; Zito F; Colucci G; Paradiso A; Silvestris N
J Cell Physiol; 2011 Jul; 226(7):1934-9. PubMed ID: 21506124
[TBL] [Abstract][Full Text] [Related]
19. Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer.
Kim DH; Kim JS; Park JH; Lee SK; Ji YI; Kwon YM; Shim YM; Han J; Park J
Cancer Res; 2003 Oct; 63(19):6206-11. PubMed ID: 14559805
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.
Esteller M; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Watkins DN; Issa JP; Sidransky D; Baylin SB; Herman JG
Cancer Res; 2000 May; 60(9):2368-71. PubMed ID: 10811111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]